Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Nippon Yakin Kogyo Co Ltd
TSE:5480
|
JP |
|
Vishal Fabrics Ltd
NSE:VISHAL
|
IN |
|
Whitecap Resources Inc
TSX:WCP
|
CA |
|
Aumann AG
XETRA:AAG
|
DE |
|
I
|
Integrated Waste Solutions Group Holdings Ltd
HKEX:923
|
HK |
|
Multiconsult ASA
OSE:MULTI
|
NO |
|
Naturhouse Health SA
MAD:NTH
|
ES |
|
Q
|
Qingling Motors Co Ltd
SWB:QIN
|
CN |
|
C
|
CMC Magnetics Corp
TWSE:2323
|
TW |
|
H
|
Hubei Guochuang Hi-tech Material Co Ltd
SZSE:002377
|
CN |
|
Groep Brussel Lambert NV
XBRU:GBLB
|
BE |
|
Venky's (India) Ltd
NSE:VENKEYS
|
IN |
|
F
|
Fukui Computer Holdings Inc
TSE:9790
|
JP |
|
C
|
China Railway Hi-tech Industry Corp Ltd
SSE:600528
|
CN |
|
Bank of Jiangsu Co Ltd
SSE:600919
|
CN |
|
Chatwork Co Ltd
TSE:4448
|
JP |
|
Baiyin Nonferrous Group Co Ltd
SSE:601212
|
CN |
|
Hellenic Telecommunications Organization SA
OTC:HLTOF
|
GR |
|
H
|
Hyundai Energy Solutions Co Ltd
KRX:322000
|
KR |
|
E
|
Enex Co Ltd
KRX:011090
|
KR |
|
A
|
Amrest Holdings SE
WSE:EAT
|
ES |
|
H
|
High Tide Inc
NASDAQ:HITI
|
CA |
|
S
|
SNTEnergy Co Ltd
KRX:100840
|
KR |
Shanghai Rightongene Biotechnology Co Ltd
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 503 full-time employees. The company went IPO on 2021-05-17. The firm's main products include leukemia molecular diagnostic kits and lymphoma molecular diagnostic kits. The firm mainly provides precise gene and antigen testing services for patients with blood diseases, solid tumors and infectious diseases. The firm also provides scientific research services applied in basic research, disease typing, drug adaptability and target genetic testing. The firm mainly conducts its businesses within domestic market.
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 503 full-time employees. The company went IPO on 2021-05-17. The firm's main products include leukemia molecular diagnostic kits and lymphoma molecular diagnostic kits. The firm mainly provides precise gene and antigen testing services for patients with blood diseases, solid tumors and infectious diseases. The firm also provides scientific research services applied in basic research, disease typing, drug adaptability and target genetic testing. The firm mainly conducts its businesses within domestic market.
